CSX shareholders approve $84 million reimbursement to Mantle Ridge

Go back to CSX shareholders approve $84 million reimbursement to Mantle Ridge

CSX (CSX) PT Raised to $65 at BofA/Merrill Lynch Following Annual Meeting

June 6, 2017 8:41 AM EDT

BofA/Merrill Lynch raised its price target on CSX (NASDAQ: CSX) to $65.00 (from $56.00) while maintaining a Buy rating after attending the company's annual shareholder meeting. Hunter Harrison, president & CEO of CSX was elected to its Board of Directors and had
his $84 million reimbursement (plus tax... More